NO750246L - - Google Patents
Info
- Publication number
- NO750246L NO750246L NO750246A NO750246A NO750246L NO 750246 L NO750246 L NO 750246L NO 750246 A NO750246 A NO 750246A NO 750246 A NO750246 A NO 750246A NO 750246 L NO750246 L NO 750246L
- Authority
- NO
- Norway
- Prior art keywords
- solution
- weight
- friedelan
- ethanol
- patient
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 46
- 238000011282 treatment Methods 0.000 claims description 30
- 238000002360 preparation method Methods 0.000 claims description 25
- OFMXGFHWLZPCFL-ACRUQRPVSA-N Friedelan-3-one Natural products C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CCC(=O)[C@H]1C OFMXGFHWLZPCFL-ACRUQRPVSA-N 0.000 claims description 24
- JUUHNUPNMCGYDT-UHFFFAOYSA-N Friedelin Natural products CC1CC2C(C)(CCC3(C)C4CC(C)(C)CCC4(C)CCC23C)C5CCC(=O)C(C)C15 JUUHNUPNMCGYDT-UHFFFAOYSA-N 0.000 claims description 24
- OFMXGFHWLZPCFL-UHFFFAOYSA-N Triedelin Natural products CC12CCC3(C)C4CC(C)(C)CCC4(C)CCC3(C)C2CCC2(C)C1CCC(=O)C2C OFMXGFHWLZPCFL-UHFFFAOYSA-N 0.000 claims description 24
- OFMXGFHWLZPCFL-SVRPQWSVSA-N friedelin Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CCC(=O)[C@@H]1C OFMXGFHWLZPCFL-SVRPQWSVSA-N 0.000 claims description 24
- 206010028980 Neoplasm Diseases 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 201000011510 cancer Diseases 0.000 claims description 17
- 229930002875 chlorophyll Natural products 0.000 claims description 16
- 235000019804 chlorophyll Nutrition 0.000 claims description 16
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 14
- 239000005011 phenolic resin Substances 0.000 claims description 14
- 229920001568 phenolic resin Polymers 0.000 claims description 14
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 claims description 13
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 13
- 230000005907 cancer growth Effects 0.000 claims description 8
- 230000002401 inhibitory effect Effects 0.000 claims description 8
- 238000007865 diluting Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- KVSNMTUIMXZPLU-UHFFFAOYSA-N D:A-friedo-oleanane Natural products CC12CCC3(C)C4CC(C)(C)CCC4(C)CCC3(C)C2CCC2(C)C1CCCC2C KVSNMTUIMXZPLU-UHFFFAOYSA-N 0.000 claims 1
- YFKBKEUBAZXAGG-UHFFFAOYSA-N friedelan Natural products CC1C(=O)CCC2(C)C3CCC4(C)C5CC(C)(C)CCC5(C)CCC4(C)C3CCC12C YFKBKEUBAZXAGG-UHFFFAOYSA-N 0.000 claims 1
- 239000000243 solution Substances 0.000 description 8
- 235000012054 meals Nutrition 0.000 description 6
- 230000004596 appetite loss Effects 0.000 description 5
- 208000019017 loss of appetite Diseases 0.000 description 5
- 235000021266 loss of appetite Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000006593 Urologic Neoplasms Diseases 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 206010021654 increased appetite Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX15306174 | 1974-08-08 | ||
| US52141074A | 1974-11-06 | 1974-11-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO750246L true NO750246L (nl) | 1976-02-10 |
Family
ID=26641075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO750246A NO750246L (nl) | 1974-08-08 | 1975-01-28 |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS5126210A (nl) |
| CA (1) | CA1026672A (nl) |
| DE (1) | DE2508338C2 (nl) |
| DO (1) | DOP1975002269A (nl) |
| FR (1) | FR2281103A1 (nl) |
| GB (1) | GB1475651A (nl) |
| IL (1) | IL46517A (nl) |
| IN (1) | IN142315B (nl) |
| IT (1) | IT1056277B (nl) |
| LU (1) | LU71933A1 (nl) |
| NL (1) | NL184665C (nl) |
| NO (1) | NO750246L (nl) |
| PH (1) | PH12112A (nl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT100939A (pt) * | 1992-10-08 | 1994-05-31 | Ineti Inst Nac Engenh E Tecnol | Novos triterpenoides e seco-triterpenoides com aplicacao como agentes bioactivos |
-
1975
- 1975-01-28 IL IL46517A patent/IL46517A/xx unknown
- 1975-01-28 NO NO750246A patent/NO750246L/no unknown
- 1975-01-28 GB GB369075A patent/GB1475651A/en not_active Expired
- 1975-02-06 PH PH16778A patent/PH12112A/en unknown
- 1975-02-14 CA CA220,209A patent/CA1026672A/en not_active Expired
- 1975-02-26 FR FR7505927A patent/FR2281103A1/fr active Granted
- 1975-02-26 DE DE2508338A patent/DE2508338C2/de not_active Expired
- 1975-02-27 LU LU71933A patent/LU71933A1/xx unknown
- 1975-03-05 IN IN428/CAL/1975A patent/IN142315B/en unknown
- 1975-03-06 JP JP50026595A patent/JPS5126210A/ja active Pending
- 1975-03-20 NL NLAANVRAGE7503371,A patent/NL184665C/nl not_active IP Right Cessation
- 1975-03-28 IT IT09377/75A patent/IT1056277B/it active
- 1975-05-24 DO DO1975002269A patent/DOP1975002269A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1026672A (en) | 1978-02-21 |
| IL46517A0 (en) | 1975-05-22 |
| IL46517A (en) | 1978-10-31 |
| JPS5126210A (nl) | 1976-03-04 |
| FR2281103B1 (nl) | 1980-02-15 |
| PH12112A (en) | 1978-11-02 |
| DE2508338A1 (de) | 1976-02-19 |
| DOP1975002269A (es) | 1989-07-07 |
| GB1475651A (en) | 1977-06-01 |
| NL184665C (nl) | 1989-10-02 |
| FR2281103A1 (fr) | 1976-03-05 |
| NL7503371A (nl) | 1976-02-10 |
| IT1056277B (it) | 1982-01-30 |
| DE2508338C2 (de) | 1985-08-14 |
| LU71933A1 (nl) | 1977-01-06 |
| IN142315B (nl) | 1977-06-25 |
| AU7829775A (en) | 1976-08-19 |
| NL184665B (nl) | 1989-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Way | Results of a planned attack on carcinoma of the vulva | |
| NO750246L (nl) | ||
| CN109432085A (zh) | 宽缨酮在制备防治男性迟发性性腺功能减退症药物、食品和保健品中的应用 | |
| Pharmaceutical Society of Great Britain | British pharmaceutical codex | |
| Potter | A Handbook of materia medica, pharmacy and therapeutics | |
| Potter | A Compend of Materia Medica, Therapeutics and Prescription Writing, with Especial Reference to the Physiological Actions of Drugs | |
| Potter | Therapeutics, materia medica, and pharmacy... | |
| Bethea | The Year Book of General Therapeutics | |
| CN104623127A (zh) | 一种用于治疗足癣的药物及其制备方法 | |
| Potter | A Compend of materia medica, therapeutics, and prescription writing, with especial reference to the physiological action of drugs; based on the 8th revision of the US pharmacopoeia including also many unofficial remedies | |
| CN101024013B (zh) | 一种治疗结核病的药物 | |
| JPH01132531A (ja) | 癌予防薬およびその製造方法 | |
| Chand | Verrucae (warts) | |
| Tombleson | Multiple Malignancy | |
| Stein | ened, almost cystic center. Microscopic study revealed that | |
| Potter | Therapeutics, Materia Medica, and Pharmacy: The Special Therapeutics of Diseases and Symptoms, the Physiological and Therapeutical Actions of Drugs, the Modern Materia Medica, Official and Practical Pharmacy, Prescription Writing, and Antidotal and Antagonistic Treatment of Poisoning | |
| Mitchell | Treatment of Syphilis by Salvarsan | |
| Reid | Hazards of Purgation | |
| Row | ologitticry shame. 3 | |
| Olapade | Clinical evaluation of the potentials of Rauvolfia vomitoria based extract in the treatment of haemorrhoids and anal prolapse in Nigeria | |
| ADVAIR et al. | What is ADVAIR DISKUS? | |
| BRITM | ANNUAL MUSEUM. | |
| Watson | Observations on Some New Remedies (Made in Edinburgh Royal Infirmary) | |
| Potter | A Handbook of Materia Medica, Pharmacy, and Therapeutics, Including the Physiological Action of Drugs, the Special Therapeutics of Disease, Official and Practical Pharmacy, and Minute Directions for Prescription Writing | |
| HERPES | A SPORADIC CASE OF MYOCLONUSI MIULTIPLEX. TIRE following notes on a man who was stated to have delusions and hallucinations may be of initerest. |